Significance of preoperative thrombocytosis in epithelial ovarian cancer

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 1, 2010, Pages 54-56

  Crasta, Julian A ^a   Premlatha, T S ^a   Krishnan, Suniti M ^a   Vallikad, Elizabeth ^a   Rameshkumar, Karuna ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Cancer; Ovarian cancer; Platelets; Thrombocytosis

Indexed keywords

HEMOGLOBIN; PACLITAXEL;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CHI SQUARE TEST; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OVARY CANCER; PREOPERATIVE THROMBOCYTOSIS; PROGNOSIS; RETROSPECTIVE STUDY; STUDENT T TEST; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR GROWTH;

FEMALE; HUMANS; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77749335631     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.59184     Document Type: Article

References (21)

1. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999;245:295-300.
2. Gupta G P, Massague J. Platelets and metastasis revisited: a novel fatty link. J Clin Invest 2004;114:1691-3.
3. O'Keefe SC, Marshall F F, Issa MM, Harmon M P, Petros JA. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002;168:1378-80.
4. Ikeda M, Furukawa H, Imamura H, Shimizu J, Isida H, Masutani S, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287-91.
5. Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2002;2:311-5.
6. Schwartz Re, Keny H. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology 2001;48:1493-8.
7. Costantini V, Zacharski LR, Moritz TE, Edwards RL. The platelet counts in lung and colon. Thromb Haemost 1990;64:501-5.
8. Tamussino K F, Gucer F, Reich O, Moser F, Petru E, Scholz HS. Pretreatment hemoglobin, platelet count and prognosis in endometrial carcinoma. Int J Gynecol Cancer 2001;11:236-40.
9. Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthraller A, Kainz C, et al. Tumor anemia and thrombocytosisin patients with vulval cancer. Tumor Biol 2000;21:309-14.
10. Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2000;78:137-42.
11. Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. The prognostic significance of thrombocytosisin epithelial ovarian carcinoma. Gynecol Oncol 2004;92:211-4.
12. Zeimet AG, Marth C, Muller Holzner E, Daxenbichler G, Dapunt O. Significance of thrombocytosisin patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994;170:549-54.
13. Menczer J, Schejter E, Geva D, Ginath S, Zakut H. Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 1998;12:82-4.
14. Soonthorhthum T, Suraseraneewong V, Kengsakol K, Wijaithum K, Kasemsan P, Prommatt S. Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai 2007;90:1495-500.
15. Levin J, Conley CL. Thrombocytosis associated with malignant disease. Arch Int Med 1964;114:497-500.
16. Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastasis. Ann Intern Med 1981;95:636-41.
17. Tuszynski G P, Nicosia R F. The role of thrombospondin-1 I tumor progression and angiogenesis. Bioessays 1996;18:71-6.
18. Natahn FE, Hernandez E, Dunton CJ, Treat J, Swittalska HI, Joseph RR, et al. Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer 1994;73:2853-8.
19. Trikha M, Nakada M T. Platelets and cancer: implications for antiangiogenic therapy. Semin Thromb Hemost 2002;28:39-44.
20. Boucharaba A Platelet derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004;1714-25.
21. Gastl G, Plante M, Finstad CL, Wong G Y, Federici MG, Bander NH, et al. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 1993;83:433-41.